Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06737809 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

IP-coated Revision Hip Implants

Study acronym: HIPrevision
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 1 to 2 Eligibility criteria expanded, about 33 wordsv5 Show 1 more changeShow less
    • Eligibility criteria expanded, about 33 words

    See this version in full on ClinicalTrials.gov ↗

  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of May 2025 to Jun 25, 2025v4 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of May 2025 to Jun 25, 2025
  3. Start date: Mar 2025 to May 2025v3
  4. Start date: Dec 2024 to Mar 2025 Secondary endpoints revised (9)v2 Show 1 more changeShow less
    • Secondary endpoints revised (9)

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aesculap AG
32 trials monitored
See 6 trials at risk
The primary aim of the clinical investigation is to demonstrate the efficacy of a silver-based antimicrobial coating on hip implants in the reduction of periprosthetic infections in revision hip arthroplasty due to periprosthetic infection.
Trial Details
NCT Number NCT06737809
Lead Sponsor Aesculap AG
Conditions Peri-Prosthetic Joint Infection
Enrollment 268 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov